Cargando…
Enzalutamide Reduces Oxycodone Exposure in Men with Prostate Cancer
BACKGROUND AND OBJECTIVE: Up to 90% of patients with castration-resistant prostate cancer (CRPC) will develop symptomatic bone metastases requiring pain medication, with opioids being the mainstay of therapy in treating moderate and severe pain. Enzalutamide is an androgen receptor antagonist for th...
Autores principales: | Detert Oude Weme, S. E. H., Hulskotte, L. M. G., Vervenne, W. L., Imholz, A. L. T., Cremers, R. G. H. M., Taxis, K., Reyners, A. K. L., van Berlo-van de Laar, I. R. F., Jansman, F. G. A., Benoist, G. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338391/ https://www.ncbi.nlm.nih.gov/pubmed/37162620 http://dx.doi.org/10.1007/s40262-023-01255-1 |
Ejemplares similares
-
Identifying patients with metformin associated lactic acidosis in the emergency department
por: van Berlo-van de Laar, I. R. F., et al.
Publicado: (2020) -
Binding interactions with sevelamer and polystyrene sulfonate in vitro
por: van Berlo‐van de Laar, Inge R.F., et al.
Publicado: (2021) -
Extracorporeal treatment of metforminassociated lactic acidosis in clinical practice: a retrospective cohort study
por: van Berlo-van de Laar, Inge R.F., et al.
Publicado: (2020) -
Probing the regulatory effects of specific mutations in three major binding domains of the pleiotropic regulator CcpA of Bacillus subtilis
por: Detert Oude Weme, Ruud, et al.
Publicado: (2015) -
Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: An Evaluation of Treatment Options
por: van Leeuwen, Roelof W. F., et al.
Publicado: (2017)